tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MaxCyte sees FY25 core revenue flat to down 10%

MaxCyte (MXCT) now expects to end 2025 with at least $155M in total cash, cash equivalents and investments.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1